Cross presentation of antigen by dendritic cells: mechanisms and implications for immunotherapy.
Dendritic cells (DCs) possess the specialized potential to present exogenously derived antigen to cytotoxic T lymphocytes to elicit an immune response. This process, termed cross presentation, is crucial in the generation of immune response to viruses, tumors and in autoimmune disease. The ability o...
Huvudupphovsmän: | Sachamitr, P, Fairchild, P |
---|---|
Materialtyp: | Journal article |
Språk: | English |
Publicerad: |
2012
|
Liknande verk
Liknande verk
-
iPS cells reprogrammed from primary dendritic cells provide an abundant source of immunostimulatory dendritic cells for use in immunotherapy
av: Horton, C, et al.
Publicerad: (2019) -
Induced pluripotent stem cells: challenges and opportunities for cancer immunotherapy.
av: Sachamitr, P, et al.
Publicerad: (2014) -
Directed differentiation of human induced pluripotent stem cells into dendritic cells displaying tolerogenic properties and resembling the CD141+ subset
av: Sachamitr, P, et al.
Publicerad: (2018) -
Induced pluripotent stem cells: Challenges and opportunities for cancer immunotherapy
av: Patty eSachamitr, et al.
Publicerad: (2014-04-01) -
STING-activating dendritic cell-targeted nanovaccines that evoke potent antigen cross-presentation for cancer immunotherapy
av: Nguyen Thi Nguyen, et al.
Publicerad: (2024-12-01)